Construction Press Releases
SEE OTHER BRANDS

Your construction news from the world

Construction Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Construction Press Releases.

Press releases published on May 18, 2025

POPEcoin Raises $1.5 Million in Ten Days with No VCs, No Taxes, and No Apologies

POPEcoin Raises $1.5 Million in Ten Days with No VCs, No Taxes, and No Apologies

ROME, May 18, 2025 (GLOBE NEWSWIRE) -- In an economy where memecoins often rise and fall within the same week, POPEcoin ($POPE) has managed to carve out a real foothold—raising $1.5 million in just ten days, without venture capital, early access …

Nimanode: Powering the First No-Code AI Agent Platform Built on XRP Ledger

Nimanode: Powering the First No-Code AI Agent Platform Built on XRP Ledger

LEEDS, United Kingdom, May 18, 2025 (GLOBE NEWSWIRE) -- Nimanode, a first-of-its-kind AI automation platform has announced their project kickoff by emphasising they will be building on the XRP Ledger. As a platform designed to power a new era of autonomous …

Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress

Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress

 Two New Analyses from SEQUOIA-HCM on Effect of Aficamten Between Patients with Mild and Moderate-to-Severe Symptoms, and Across Geographic Regions HEOR Analyses of Real-World Data Reveal Disparities in Outcomes In Females and Older Patients with Non- …

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

 Slowing of progression of disease observed via MRI at 24 months Improvements in outcomes and reduction in sorbitol maintained through 24 months Statistically significant correlation between absolute reduction in sorbitol and change in 10MWRT and CMT-FOM …

Intellia Announces Positive Two-Year Follow-Up Data from Ongoing Phase 1 Study of Nexiguran Ziclumeran (nex-z), in Patients with Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy at Peripheral Nerve Society Annual Meeting

Intellia Announces Positive Two-Year Follow-Up Data from Ongoing Phase 1 Study of Nexiguran Ziclumeran (nex-z), in Patients with Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy at Peripheral Nerve Society Annual Meeting

Deep, durable and consistent reductions in TTR were sustained at two years, following a one-time dose of nex-z Clinically meaningful improvements in ATTRv-PN related outcomes observed at 24 months compared to baseline, including in patients who were …

Bitcoin Solaris Unveils Hybrid Consensus Architecture Ahead of Nova App Mining Launch

Bitcoin Solaris Unveils Hybrid Consensus Architecture Ahead of Nova App Mining Launch

TALLINN, Estonia, May 18, 2025 (GLOBE NEWSWIRE) -- Bitcoin Solaris is officially unveiling its advanced hybrid consensus architecture, purpose-built to support fast, decentralized applications with user-integrated mining and sub-2-second finality. This …

ZA Miner bietet passive Einkommensmöglichkeiten mit Kryptowährungen und flexiblen Verträgen

ZA Miner bietet passive Einkommensmöglichkeiten mit Kryptowährungen und flexiblen Verträgen

ZA Miner-Bild MIDDLESEX, Vereinigtes Königreich, May 18, 2025 (GLOBE NEWSWIRE) -- Als Reaktion auf das wachsende Interesse am Mining digitaler Vermögenswerte hat ZA Miner eine optimierte Infrastruktur eingeführt, die Nutzern zugängliche und sichere …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service